ARTICLE | Clinical News
EpiCept preclinical data
October 29, 2007 7:00 AM UTC
In mouse models of NSCLC and breast cancer, EPC2407 significantly enhanced the activity of Avastin bevacizumab, Sutent sunitinib or cisplatin compared with any agent alone. The small molecule vascul...